In other countries
The same active substances on other registers, the same brand first.
- Emblaveo 1,5 G/0,5 G Polvo Para Concentrado Para Solucion Para PerfusionSpain · 542 mg + 1500 mg · polvo para concentrado para solución para perfusión · Pfizer Europe Ma EeigSame brand
- EmblaveoEuropean Union · Pfizer Europe MA EEIGSame brand
- EmblaveoItaly · Polvere per concentrato per soluzione per infusione · Pfizer Europe Ma EeigSame brand
- Emblaveo 1,5 g/0,5 g poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Pfizer Europe MA EEIGSame brand
- Emblaveo Powder for Concentrate for Solution for Infusion 1.5G/0.5GSingapore · 0.5 g/vial + 1.5 g/vial · injection, powder, for solution · Pfizer Private LimitedSame brand
- EmblaveoUnited States · 0.5GM BASE/VIAL; 1.5GM/VIAL · powder · AbbvieSame brand
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Register
- Croatia (HALMED)
- Status
- Marketed
- Status in the register
- stavljeno u promet; nema nestašice
- Registration
- 17249
- ATC code
- J01DF51
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni